🇺🇸 EDETATE DISODIUM in United States

906 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain In Extremity — 93 reports (10.26%)
  2. Musculoskeletal Pain — 92 reports (10.15%)
  3. Arthralgia — 91 reports (10.04%)
  4. Condition Aggravated — 90 reports (9.93%)
  5. Drug Ineffective — 90 reports (9.93%)
  6. Gastrointestinal Toxicity — 90 reports (9.93%)
  7. Hepatotoxicity — 90 reports (9.93%)
  8. Infection — 90 reports (9.93%)
  9. Musculoskeletal Stiffness — 90 reports (9.93%)
  10. Neoplasm Malignant — 90 reports (9.93%)

Source database →

EDETATE DISODIUM in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is EDETATE DISODIUM approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for EDETATE DISODIUM in United States?

Marketing authorisation holder not available in our data.